Chlorosartan potassium tablets have a certain lowering effect of urinary protein, the effect of individual differences, can not be generalized.
Chlorosartan potassium tablets is a kind of renin-angiotensin inhibitor, this kind of drug can not only reduce blood pressure to achieve the purpose of reducing urinary protein, and at the same time can reduce the glomerular intracapsular pressure, improve renal hyperfiltration, so as to reduce urinary protein, play a role in protecting the kidneys and preventing renal fibrosis. Its effect of lowering urinary protein has individual differences and cannot be generalized.
This drug is the first-line drug for the treatment of urinary protein caused by kidney disease, and patients without contraindications can generally apply such drugs.
If the patient’s condition is more serious, chlorosartan potassium tablets alone may not be able to make the urine protein completely reduced to normal, then according to the patient’s condition need to add glucocorticoids (prednisone acetate) or other immunosuppressants (cyclosporine, cyclophosphamide).
Chlorosartan potassium tablets may cause a transient increase in creatinine and hyperkalemia, may also lead to hypotension, so it must be used under the guidance of specialists, and regular review of renal function and serum potassium ions, do not self-medication.